Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2025-12-24 @ 11:34 PM
NCT ID: NCT02566356
Eligibility Criteria: Inclusion Criteria for Patients: * Male * SCID-IV confirmed diagnosis of schizophrenia or schizoaffective disorder * Clinically stable * No changes to medications for the past week Inclusion Criteria for Healthy Controls: * Male * SCID-IV confirmed no diagnosis of a current Axis I disorder within the last year Exclusion Criteria for Patients and Healthy Controls: * Meeting criteria for current substance abuse or dependence or illicit drug use within the last month (nicotine use is acceptable) as determined by a Urine Toxicology Drug Screening * Any illness that affects the nasal passages and impairs the delivery of a nasal spray * Presence of any neurological or significant medical disorder, including medical illnesses that could interfere with physiological recording such as cardiac arrhythmias * A pacemaker, extensive dental work, or any magnetic metal implants and upper body tattoos * Pregnancy * Claustrophpbia * Hearing difficulties * A history of seizures * Failure to receive a passing score on the reading test Additional Exclusion Criteria for Patients and Healthy Controls: * Taking any psychotropic medication or any medication that affects the autonomic or cardiovascular systems. * Schizophrenia or other psychotic disorder in a first degree relative * Failure to receive a passing score on the MOCA
Healthy Volunteers: True
Sex: MALE
Minimum Age: 18 Years
Maximum Age: 50 Years
Study: NCT02566356
Study Brief:
Protocol Section: NCT02566356